99 related articles for article (PubMed ID: 4149356)
1. Letter: Salicylazosulfapyridine in clinical practice.
Daz KM
Gastroenterology; 1974 Feb; 66(2):326. PubMed ID: 4149356
[No Abstract] [Full Text] [Related]
2. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
Das KM; Eastwood MA; McManus JP; Sircus W
N Engl J Med; 1973 Sep; 289(10):491-5. PubMed ID: 4146729
[No Abstract] [Full Text] [Related]
3. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease.
Das KM; Eastwood MA
Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):514-20. PubMed ID: 241531
[TBL] [Abstract][Full Text] [Related]
4. Saliva: plasma concentration relationships for sulphapyridine following sulphasalazine administration to normal volunteers and patients with inflammatory bowel disease.
Day JM; Houston JB
Br J Clin Pharmacol; 1980 Jan; 9(1):91-4. PubMed ID: 6101957
[No Abstract] [Full Text] [Related]
5. Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis.
Bondesen S; Nielsen OH; Schou JB; Jensen PH; Lassen LB; Binder V; Krasilnikoff PA; Danø P; Hansen SH; Rasmussen SN
Scand J Gastroenterol; 1986 Aug; 21(6):693-700. PubMed ID: 2875518
[TBL] [Abstract][Full Text] [Related]
6. The role of the colon in the metabolism of salicylazosulphapyridine.
Das KM; Eastwood MA; McManus JP; Sircus W
Scand J Gastroenterol; 1974; 9(2):137-41. PubMed ID: 4150441
[No Abstract] [Full Text] [Related]
7. [Pharmacokinetics of Azulfidine/Salazopyrin in healthy humans and in patients with chronic inflammatory bowel diseases].
Van Hees PA
Z Gastroenterol Verh; 1981 Jun; 19():7-14. PubMed ID: 6168136
[No Abstract] [Full Text] [Related]
8. Role of the intestinal flora in the acetylation of sulfasalazine metabolites.
Dull BJ; Salata K; Goldman P
Biochem Pharmacol; 1987 Nov; 36(21):3772-4. PubMed ID: 2890356
[No Abstract] [Full Text] [Related]
9. Colonic azodisalicylate metabolism determined by in vivo dialysis in healthy volunteers and patients with ulcerative colitis.
Lauritsen K; Hansen J; Ryde M; Rask-Madsen J
Gastroenterology; 1984 Jun; 86(6):1496-500. PubMed ID: 6143704
[TBL] [Abstract][Full Text] [Related]
10. Cholestyramine-induced inhibition of salicylazosulfapyridine (sulfasalazine) metabolism by rat intestinal microflora.
Pieniaszek HJ; Bates TR
J Pharmacol Exp Ther; 1976 Jul; 198(1):240-5. PubMed ID: 6792
[TBL] [Abstract][Full Text] [Related]
11. Disposition of 5-aminosalicylic acid, the active metabolite of sulphasalazine, in man.
Fischer C; Maier K; Stumpf E; von Gaisberg U; Klotz U
Eur J Clin Pharmacol; 1983; 25(4):511-5. PubMed ID: 6140167
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of salicylazosulfapyridine in healthy subjects and in patients with ulcerative colitis. Effects of colectomy and of phenobarbital.
Schröder H; Lewkonia RM; Price Evans DA
Clin Pharmacol Ther; 1973; 14(5):802-9. PubMed ID: 4147120
[No Abstract] [Full Text] [Related]
13. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
Rubinstein BE
Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
[No Abstract] [Full Text] [Related]
14. Distribution studies of salicylazosulfapyridine and its metabolites.
Peppercorn MA; Goldman P
Gastroenterology; 1973 Feb; 64(2):240-5. PubMed ID: 4405598
[No Abstract] [Full Text] [Related]
15. [Estimations of the serum levels of sulfapyridine on patients treated with sulfasalazin (author's transl)].
Eitner K; Hippius M; Reinicke C
Dtsch Z Verdau Stoffwechselkr; 1982; 42(1):14-9. PubMed ID: 6122556
[TBL] [Abstract][Full Text] [Related]
16. Salicylazosulfapyridine in clinical practice.
Goldman P; Peppercorn MA
Gastroenterology; 1973 Jul; 65(1):166-9. PubMed ID: 4146457
[No Abstract] [Full Text] [Related]
17. Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC; Hanauer SB
Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
[TBL] [Abstract][Full Text] [Related]
18. Will there be a next generation of sulfasalazine?
Goldman P
Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420
[No Abstract] [Full Text] [Related]
19. The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.
Das KM; Eastwood MA; McManus JP; Sircus W
Gut; 1973 Aug; 14(8):631-41. PubMed ID: 4147555
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic determination of aminosalicylate, sulfapyridine and their metabolites. Its application for pharmacokinetic studies with salicylazosulfapyridine in man.
Fischer C; Klotz U
J Chromatogr; 1979 Feb; 162(2):237-43. PubMed ID: 33196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
